Subscribers to the guidelines are able to use these search facilities to explore more than 600 drug monographs

Practical points

Tube types137

Nasogastric (NG) - inserted into the stomach via the nose.

Nasojejunal (NJ) - inserted into the jejunum via the nose. These tubes may also have a gastric port.

Percutaneous endoscopic gastrostomy (PEG) - inserted into the stomach via the abdominal wall.

Percutaneous endoscopic jejunostomy (PEJ) - inserted into the jejunum via the abdominal wall.

Percutaneous endoscopic gastro-jejunostomy (PEGJ) - inserted into the jejunum via the abdominal wall and through the stomach.

Nasogastric and nasojejunal tubes are long fine-bore tubes with a large surface area for potential drug absorption and may block easily due to their small bore. Percutaneous endoscopic gastrostomy, and jejunostomy tubes are short tubes with a wider bore.

When administering medicines via a tube that ends in the jejunum, sterile water should be used because the acid barrier in the stomach is by-passed. Drug absorption may be unpredictable if the tube extends beyond the drug's main site of absorption (e.g. cefalexin, ketoconazole).137 There is a higher risk of diarrhoea with sorbitol-containing liquids and hypertonic solutions when administered directly into the jejunum as the buffering effect of the gastric contents is lost.26,155,245,593

The material from which the tube is made can have an effect on the frequency of tube occlusion. Polyurethane tubes have been found to be less likely than silicone tubes to cause clotting of the enteral feed solution.442

Tube size

Enteral tube sizes are usually expressed in French size. The internal and external diameters may be printed on the original packaging, but sometimes only French size is listed. The table below gives approximate inner diameters of enteral feeding tubes - these may differ slightly between manufacturers.422,446

French Size Inner diameter (mm)
5 1.10
6 1.37
8 1.96
10 2.54
12 2.67

Tube position

Tube tips can easily become dislodged by movement. Tube tip position should be tested using pH indicator paper, or according to local guidelines. Blue litmus paper is no longer considered to be appropriate for use, as it may not distinguish between bronichial and gastric placement.118

Tube tip position is most accurately checked by radiography, but in order to minimise exposure to radiation and to reduce handling of the patient, pH testing is the preferred method for most patients (excepting neonates). pH indicator strips should have 0.5 gradations and a range including 1-6. It is particularly important to be able to distinguish at the pH 5-6 range.120

Tube tip position should be checked120 : -

pH testing results120

pH 5.5 or below - Commence feeding (there have been no reported cases of pulmonary aspirates below this figure).

pH above 6 - Do not feed. Wait 1 hour and try again (to allow feed to leave the stomach, and gastric acid levels to rise).

Patients on antacids, H2 antagonists, or proton pump inhibitors may have gastric aspirates with pH of 6 or above. Seek advice and alternative methods of checking tube tip position in these patients if aspirate pH is high.120

General handling of enteral feeding tubes

Carers should wear gloves when handling enteral feeding tubes and preparing medicines for administration (e.g. when crushing tablets).

An appropriate enteral syringe should be used for administration of medication. Intravenous syringes should NOT be used due to the risk of accidental parenteral administration. The use of intravenous syringes has led to fatalities when medications for enteral use have been accidentally given intravenously.

Syringes

Since the introduction of ISO 80369-3 (click here for more information), enteral tubes and syringes have been re-designed with fittings that are only compatible with each other, and not with intravenous devices and other equipment which may be in use in clinical environments. Most enteral tubes, therefore, can only accept ISO 80369-3 enteral syringes, and other syringes will not connect to them without the use (not recommended) of adapter devices.

ISO 80369-3 enteral syringes have a substantial dead-space at the tip, which should not be allowed to fill with liquid medicine. If this space fills with liquid, and if the syringe is then connected to an enteral tube, there is a risk of overdosage and / or leakage (with resulting medicine waste and contamination of the area). The dead-space can be prevented from filling by the use of appropriate bottle adapters or medicine straws which are available from the syringe manufacturers.

ISO 80369-3 enteral syringes should generally not be used to administer liquid medicines orally. If it is necessary to use them orally (for instance whilst oral syringes are being obtained) it is essential to ensure that the dead-space does not fill with liquid medicine - this can be done by using the available bottle adapters or medicine straws. Enteral syringes should not be immersed ("dunked") in liquid medicine (the "cup-fill method") when doses are being drawn up.

Catheter-tipped syringes should not be used for measuring oral liquid medicines due to the large dead-space volume in the catheter tip. This can be up to 2mL in some cases, which can lead to doses in excess of those intended being administered to the patient.

Luer-tipped syringes should never be used to measure oral medicines, as this risks accidental connection of oral medication to intravenous catheters, and resulting intravenous administration and patient harm.

Dedicated oral syringes should be used to administer oral liquid medicines. The dead-space volume in these syringes is much smaller, but can still be significant for highly-concentrated drugs such as digoxin elixir when the dose volume is small. It is important to remember that the measured dose in these syringes is from the graduation mark to the base of the barrel - the tip of the syringe is designed to fill with liquid medicine, and should remain full after the dose has been given. This volume in the tip is in excess of the volume measured (i.e. it is not necessary to try and flush out the medicine which remains in the tip, and to do so would result in giving a dose in excess of what was intended).

Oral syringes are generally coloured to distinguish them from intravenous syringes. In centres where oral and enteral syringes are the same colour, the two should be stored separately and clearly labelled to avoid confusion. Oral syringes are not always sterile, and they may be re-used for the same patient. They should be clearly labelled with the patient details, washed in hot soapy water immediately after each use, and allowed to dry in air. Immunocompromised patients may require the use of sterile equipment to reduce infection risk.

Some enteral syringes are single-use only, and others can be re-used for the same patient. Immunocompromised patients and those with enteral feeding tubes which terminate in the jejunum should usually be managed with single-use, sterile syringes.

All equipment used for administering medicines must be cleaned in between each use to prevent cross-contamination of medicines. Particular care should be taken when handling drugs to which patients frequently suffer allergies, e.g. the penicillins.

Water

For patients who are not immunosuppressed, enteral feeding tubes which terminate in the stomach should be flushed with freshly drawn tap water.697

For immunosuppressed patients, and all tubes which terminate in the jejunum, the tubes should be flushed with cooled freshly boiled water, or sterile water.697

Some medications may interact with ions in water, so where the monograph indicates, de-ionised water (e.g. water for injection, water for irrigation) should be used. A separate bottle should be used for each patient, and discarded at the end of 24 hours.

Flushing enteral feeding tubes

Tube flushing should be done using a push-pause technique to create turbulence within the tube which helps to dislodge particles. Enteral feeding tubes should be flushed with 30mL of water after the feed is stopped and before any medications are given, then with 10mL of water between medications to prevent drug-drug interactions. When all the medications have been administered, flush the tube with at least 30mL of water again before restarting the feed. This procedure reduces the risk of tube blockage and helps with the delivery of the drug to the stomach.1 If the patient is fluid-restricted, consult your Pharmacist or the prescriber.

Enteral feed interactions with gastric acid have been associated with coagulation of the feed and tube occlusion. For this reason, it is recommended that if gastric contents are to be aspirated from an enteral feeding tube through which feed has previously been delivered, the tube should be flushed before and after aspiration.214 Some authors also recommend flushing the enteral feeding tube at the end of each period of feeding, as retrograde migration of gastric juices can occur, which may cause coagulation of any feed remaining in the tube.214

Drug absorption via enteral feeding tubes

There are two main consequences for drug absorption via the stomach when an enteral feeding tube is in place.1
1. The delivery of drugs directly into the stomach bypasses the normal enteral route where saliva may assist degradation of the drug.
2. The residence time in the stomach is reduced. Absorption of drug will be impaired if prolonged contact with the acid environment of the stomach is required for drug dissolution. When an enteral tube terminating in the jejunum (NJ, PEJ, PEGJ) is used the acid environment of the stomach is bypassed altogether, which can result in only partial or no absorption of the drug.

Some studies have shown that drug absorption is reduced when administered via enteral feeding tubes.555 Concommitant patient conditions (often those which may have resulted in the need for the enteral feeding tube in the first place) such as recent surgery, or acute illness, may also account for reduced absorption.

Gastric motility and nasogastric suction

Gastric motility can inhibit absorption of medications administered via nasogastric or percutaneous gastrostomy tubes. If motility is believed to be a problem, referral to the local Nutrition team is advised.

Some drugs have been used to try and aid gastric motility through their prokinetic side effects. Metoclopramide (10mg three times a day) and erythromycin (250mg two or three times a day, preferably by the intravenous route) are the most commonly used.90 Metoclopramide increases gastric emptying by contracting gastric smooth muscle.2

In patients with slow gastric emptying, it may be advisable to suspend nasogastric drainage / nasogastic suction following dosing for sufficient time to allow the dose to be absorbed.90

Medications should not be administered through enteral tubes on free-drainage.137

When a patient who was previously on oral medication has an enteral feeding tube fitted and is likely to have medication administered via this route, contact Pharmacy for advice.

Every reasonable attempt has been made to ensure that the information on this site is accurate and up to date. Betsi Cadwaladr University Local Health Board (East) does not authorise or take responsibility for any off-license use of medication, which should only be done with prescriber agreement.
Copyright © 2017 J Smyth, Betsi Cadwaladr University Local Health Board (East). All rights reserved
Terms and Conditions / Privacy Policy / Contact Us / Frequently asked questions / Subscription and re-subscription